Financhill
Buy
55

ILMN Quote, Financials, Valuation and Earnings

Last price:
$120.00
Seasonality move :
-3.35%
Day range:
$118.68 - $120.41
52-week range:
$68.70 - $155.53
Dividend yield:
0%
P/E ratio:
21.96x
P/S ratio:
4.31x
P/B ratio:
6.74x
Volume:
1.9M
Avg. volume:
2.3M
1-year change:
16.5%
Market cap:
$18.3B
Revenue:
$4.3B
EPS (TTM):
$5.46

Analysts' Opinion

  • Consensus Rating
    Illumina, Inc. has received a consensus rating of Leans Bullish. The company's average rating is a Leans Bullish based on 8 Buy ratings, 8 Hold ratings, and 1 Sell rating.
  • Price Target Upside
    According to analysts' consensus price target of $135.84, Illumina, Inc. has an estimated upside of 13.2% from its current price of $120.00.
  • Price Target Downside
    According to analysts, the lowest downside price target is $80.00 representing 100% downside risk from its current price of $120.00.

Fair Value

  • According to the consensus of 17 analysts, Illumina, Inc. has 13.2% upside to fair value with a price target of $135.84 per share.

ILMN vs. S&P 500

  • Over the past 5 trading days, Illumina, Inc. has overperformed the S&P 500 by 2.72% suggesting its relative strength compared to the major market average is strong at this time.

Share Buyback

  • Illumina, Inc. does have a share repurchase program in place at this time. The scale of a buyback program can materially affect share price and usually results in a higher earnings per share, all else being equal, when the share count drops.

Revenue Growth

  • Illumina, Inc. has grown year-over-year revenues for 2 quarters straight. In the most recent quarter Illumina, Inc. reported revenues of $1.2B.

Earnings Growth

  • Illumina, Inc. has grown year-over-year earnings for 1 quarter straight. In the most recent quarter Illumina, Inc. reported earnings per share of $2.17.
Enterprise value:
19.3B
EV / Invested capital:
3.65x
Price / LTM sales:
4.31x
EV / EBIT:
21.55x
EV / Revenue:
4.44x
PEG ratio (5yr expected):
-2.13x
EV / Free cash flow:
20.92x
Price / Operating cash flow:
20.33x
Enterprise value / EBITDA:
16.54x
Gross Profit (TTM):
$2.9B
Return On Assets:
13.54%
Net Income Margin (TTM):
19.58%
Return On Equity:
35.12%
Return On Invested Capital:
16.96%
Operating Margin:
22.16%
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Income Statement
Revenue $4.5B $4.4B $4.3B $1.1B $1.2B
Gross Profit $2.7B $2.9B $2.9B $728M $778M
Operating Income -$73M $1.2B $894M $202M $257M
EBITDA $357M $1.5B $1.2B $273M $324M
Diluted EPS -$7.34 -$7.72 $5.46 $1.17 $2.17
Period Ending 2021-12-31 2022-12-31 2023-12-31 2024-12-31 2025-12-31
Balance Sheet
Current Assets $2.7B $3.6B $2.6B $2.7B $3.3B
Total Assets $15.2B $12.3B $10.1B $6.3B $6.6B
Current Liabilities $1.1B $2.8B $1.6B $1.5B $1.6B
Total Liabilities $4.5B $5.7B $4.4B $3.9B $3.9B
Total Equity $10.7B $6.6B $5.7B $2.4B $2.7B
Total Debt $2.5B $3.5B $2.2B $2.5B $2.5B
Trailing 12 Months Fiscal Quarters
Period Ending 2023-12-31 2024-12-31 2025-12-31 2024-12-31 2025-12-31
Cash Flow Statement
Cash Flow Operations $477M $837M $1.1B $364M $321M
Cash From Investing -$231M -$178M -$55M -$48M $108M
Cash From Financing -$1.2B -$570M -$744M -$47M -$63M
Free Cash Flow $281M $628M $921M $335M $263M
ILMN
Sector
Market Cap
$18.3B
$25.2M
Price % of 52-Week High
77.16%
49.83%
Dividend Yield
0%
0%
Shareholder Yield
3.6%
-1.77%
1-Year Price Total Return
16.51%
-21.9%
Beta (5-Year)
1.450
0.499
Dividend yield:
0%
Annualized payout:
$0.00
Payout ratio:
--
Growth streak:
0 years

Technicals

8-day SMA
Buy
Level $117.60
200-day SMA
Buy
Level $108.49
Bollinger Bands (100)
Sell
Level 105.36 - 141.3
Chaikin Money Flow
Buy
Level 510.2M
20-day SMA
Sell
Level $132.93
Relative Strength Index (RSI14)
Sell
Level 36.14
ADX Line
Sell
Level 37.42
Williams %R
Neutral
Level -80
50-day SMA
Sell
Level $136.22
MACD (12, 26)
Sell
Level -6.57
25-day Aroon Oscillator
Sell
Level -60
On Balance Volume
Neutral
Level 409.8M

Financial Scores

Buy
Altman Z-Score (Annual)
Level (4.378)
Buy
CA Score (Annual)
Level (-0.089)
Buy
Beneish M-Score (Annual)
Level (-2.5196)
Buy
Momentum Score
Level (4)
Buy
Ohlson Score
Level (-2.1189)
Buy
Piotroski F Score (Annual)
Level (8)
Buy
Quality Ratio Score
Level (8)
Buy
Fundamental Score
Level (6)

Revenue Forecast

Earnings per Share Forecast

Company Profile

Illumina, Inc. engages in the development, manufacturing, and marketing of life science tools and integrated systems for large-scale analysis of genetic variation and function. It operates through the Core Illumina segment, which serves customers in the research, clinical and applied markets fields, and enables the adoption of a variety of genomic solutions. The firm's products include instruments, kits and reagents, selection tools, and software and analysis. Its services include sequencing and microarray services, proactive instrument monitoring, and instrument services, training, and consulting. The company was founded by David R. Walt, John R. Stuelpnagel, Anthony W. Czarnik, Lawrence A. Bock, and Mark S. Chee in April 1998 and is headquartered in San Diego, CA.

Stock Forecast FAQ

In the current month, ILMN has received 8 Buy ratings 8 Hold ratings, and 1 Sell ratings. The ILMN average analyst price target in the past 3 months is $135.84.

  • Where Will Illumina, Inc. Stock Be In 1 Year?

    According to analysts, the consensus estimate is that Illumina, Inc. share price will rise to $135.84 per share over the next 12 months.

  • What Do Analysts Say About Illumina, Inc.?

    Analysts are divided on their view about Illumina, Inc. share price and where it will be in the next 12 months. The majority of analysts rate the stock a Buy. However, a smaller subset of analysts suggest that Illumina, Inc. is a Sell and believe this share price will drop from its current level to $80.00.

  • What Is Illumina, Inc.'s Price Target?

    The price target for Illumina, Inc. over the next 1-year time period is forecast to be $135.84 according to 17 Wall Street analysts, 8 of them rate the stock a Buy, 1 rates the stock a Sell, and 8 analysts rate the stock a Hold.

  • Is ILMN A Buy, Sell Or Hold?

    According to Wall Street analysts, the consensus rating for Illumina, Inc. is a Leans Bullish. 8 of 17 analysts rate the stock a Leans Bullish at this time.

  • How Can I Buy Shares Of ILMN?

    You can purchase shares of Illumina, Inc. via an online brokerage firm such as TD Ameritrade.com, thinkorswim.com, e-trade.com, or Schwab.com. Many other digital online brokerages exist such as RobinHood and Webull where you can purchase Illumina, Inc. shares.

  • What Is The Illumina, Inc. Share Price Today?

    Illumina, Inc. was last trading at $120.00 per share. This represents the most recent stock quote for Illumina, Inc.. Yesterday, Illumina, Inc. closed at $120.00 per share.

  • How To Buy Illumina, Inc. Stock Online?

    In order to purchase Illumina, Inc. stock online, open a brokerage account, deposit funds into the account, and select an order type to purchase shares whether it be market or limit.

SEE THE 1% OF STOCKS YOU NEED TO OWN FOR MASSIVE RETURNS

GET BETTER TRADE IDEAS

Popular

Is Celestica The Best AI Stock to Buy Now?
Is Celestica The Best AI Stock to Buy Now?

Technology and hardware business Celestica (NYSE:CLS) has seen massive upward…

Will AI Disrupt SaaS Software Stocks?
Will AI Disrupt SaaS Software Stocks?

Since January 28th, software stocks in the United States have…

Why Is Meta Stock Going Higher?
Why Is Meta Stock Going Higher?

Over the last five days, shares of Instagram and Facebook…

Stock Ideas

Buy
56
Is NVDA Stock a Buy?

Market Cap: $4.6T
P/E Ratio: 64x

Sell
49
Is AAPL Stock a Buy?

Market Cap: $3.8T
P/E Ratio: 35x

Sell
44
Is GOOG Stock a Buy?

Market Cap: $3.7T
P/E Ratio: 28x

Alerts

Sell
23
CAR alert for Feb 20

Avis Budget Group, Inc. [CAR] is down 21.87% over the past day.

Buy
75
HYMC alert for Feb 20

Hycroft Mining Holding Corp. [HYMC] is up 3.81% over the past day.

Sell
1
EPAM alert for Feb 20

EPAM Systems, Inc. [EPAM] is down 16.79% over the past day.

THE #1 STOCK ANALYSIS TOOL
TO MAKE SMARTER BUY AND SELL DECISIONS

Show me the best stock